- Home
- SSP vs CMPX Comparison
SSP vs CMPX Comparison
Compare SSP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- CMPX
- Stock Information
- Founded
- SSP 1878
- CMPX 2014
- Country
- SSP United States
- CMPX United States
- Employees
- SSP N/A
- CMPX N/A
- Industry
- SSP Broadcasting
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- SSP Industrials
- CMPX Health Care
- Exchange
- SSP Nasdaq
- CMPX Nasdaq
- Market Cap
- SSP 198.7M
- CMPX 229.5M
- IPO Year
- SSP 1988
- CMPX N/A
- Fundamental
- Price
- SSP $2.08
- CMPX $1.94
- Analyst Decision
- SSP Buy
- CMPX Strong Buy
- Analyst Count
- SSP 2
- CMPX 8
- Target Price
- SSP $6.25
- CMPX $13.57
- AVG Volume (30 Days)
- SSP 957.5K
- CMPX 2.7M
- Earning Date
- SSP 05-08-2025
- CMPX 05-12-2025
- Dividend Yield
- SSP N/A
- CMPX N/A
- EPS Growth
- SSP N/A
- CMPX N/A
- EPS
- SSP 1.01
- CMPX N/A
- Revenue
- SSP $2,509,772,000.00
- CMPX $850,000.00
- Revenue This Year
- SSP N/A
- CMPX $47.65
- Revenue Next Year
- SSP $9.18
- CMPX $2,767.57
- P/E Ratio
- SSP $2.06
- CMPX N/A
- Revenue Growth
- SSP 9.46
- CMPX N/A
- 52 Week Low
- SSP $1.36
- CMPX $0.77
- 52 Week High
- SSP $4.65
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- SSP 41.91
- CMPX 48.60
- Support Level
- SSP $2.01
- CMPX $1.60
- Resistance Level
- SSP $2.29
- CMPX $2.19
- Average True Range (ATR)
- SSP 0.20
- CMPX 0.17
- MACD
- SSP -0.04
- CMPX 0.08
- Stochastic Oscillator
- SSP 8.16
- CMPX 68.35
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.